To determine whether the PI3K/Akt pathway is involved in TCO-mediated antitumor effect in lung cancer cells, we examined the phosphorylation levels of Akt (Ser473) and PI3Kp85 (Y607). The gene discussed is AKT1; the disease is lung carcinoma.